Charles Schwab’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $951K | Buy |
129,420
+18,004
| +16% | +$132K | ﹤0.01% | 2914 |
|
|
2025
Q1 | $860K | Sell |
111,416
-3,150
| -3% | -$24.3K | ﹤0.01% | 2893 |
|
|
2024
Q4 | $1.39M | Buy |
114,566
+918
| +0.8% | +$11.1K | ﹤0.01% | 2795 |
|
|
2024
Q3 | $1.43M | Buy |
113,648
+90,557
| +392% | +$1.14M | ﹤0.01% | 2805 |
|
|
2024
Q2 | $275K | Buy |
+23,091
| New | +$275K | ﹤0.01% | 3388 |
|
|
2021
Q3 | – | Sell |
-1,748
| Closed | -$57K | – | 3523 |
|
|
2021
Q2 | $57K | Sell |
1,748
-8,751
| -83% | -$285K | ﹤0.01% | 3349 |
|
|
2021
Q1 | $397K | Buy |
10,499
+3,667
| +54% | +$139K | ﹤0.01% | 3156 |
|
|
2020
Q4 | $324K | Hold |
6,832
| – | – | ﹤0.01% | 3128 |
|
|
2020
Q3 | $221K | Buy |
6,832
+1,054
| +18% | +$34.1K | ﹤0.01% | 3149 |
|
|
2020
Q2 | $255K | Buy |
+5,778
| New | +$255K | ﹤0.01% | 3114 |
|
|
2019
Q2 | – | Sell |
-3,709
| Closed | -$226K | – | 3239 |
|
|
2019
Q1 | $226K | Buy |
3,709
+762
| +26% | +$46.4K | ﹤0.01% | 3000 |
|
|
2018
Q4 | $175K | Hold |
2,947
| – | – | ﹤0.01% | 3034 |
|
|
2018
Q3 | $239K | Sell |
2,947
-443
| -13% | -$35.9K | ﹤0.01% | 3048 |
|
|
2018
Q2 | $297K | Buy |
+3,390
| New | +$297K | ﹤0.01% | 2966 |
|
|
2014
Q2 | – | Sell |
-47
| Closed | -$177K | – | 3110 |
|
|
2014
Q1 | $177K | Hold |
47
| – | – | ﹤0.01% | 2973 |
|
|
2013
Q4 | $154K | Hold |
47
| – | – | ﹤0.01% | 3010 |
|
|
2013
Q3 | $206K | Hold |
47
| – | – | ﹤0.01% | 2907 |
|
|
2013
Q2 | $162K | Buy |
+47
| New | +$162K | ﹤0.01% | 2974 |
|